Legal Representation
Attorney
LEAH D LEYENDECKER
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 18, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Mar 12, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Jan 9, 2024 | GEA1 | O | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
| Jan 9, 2024 | GECD | O | ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
| Jan 9, 2024 | CNCF | S | ACTION CONTINUING FINAL - COMPLETED | Loading... |
| Dec 21, 2023 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Dec 21, 2023 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Dec 21, 2023 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Dec 21, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 7, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 7, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 21, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 21, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 21, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 21, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 21, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 21, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 15, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 3, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 2, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Assistance in business management and product commercialization for biopharma companies to maximize product value and optimize revenue at the late stages of the product life cycle
First Use Anywhere:
Jan 1, 2022
First Use in Commerce:
Jan 1, 2022
Classification
International Classes
035